AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (4.8 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Research Article | Open Access

Association of cumulative resting heart rate exposure with rapid renal function decline: a prospective cohort study with 27,564 older adults

Xi JIANG1,2,*Xian SHAO1,2,*Xing LI1,2,3,*Pu-Fei BAI1,2Hong-Yan LIU1,2Jia-Mian CHEN1,2Wei-Xi WU1,2Zhuang CUI4Fang HOU5Chun-Lan LU5Sai-Jun ZHOU1,2( )Pei YU1,2( )
NHC Key Laboratory of Hormones and Development, Chu Hsien-I Memorial Hospital and Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin, China
Tianjin Key Laboratory of Metabolic Diseases, Tianjin Medical University, Tianjin, China
Ordos Center Hospital, Ordos, Inner Mongolia, Sudu Street, Kangbashi District, Ordos City, China
Department of Epidemiology and Health Statistics, Tianjin Medical University, Heping District, Tianjin, China
Community Health Service Center, Jiefang Road, Tanggu Street, Binhai New District, Tianjin, China

*The authors contributed equally to this manuscript

Show Author Information

Abstract

OBJECTIVE

To evaluate the prospective association between cumulative resting heart rate (cumRHR) and rapid renal function decline (RRFD) in a cohort of individuals aged 60 and older.

METHODS

In the Tianjin Chronic Kidney Disease Cohort Study, the individuals who underwent three consecutive physical examinations between 2014 and 2017, with estimated glomerular filtration rate (eGFR) greater than 60 mL/min per 1.73 m2 and aged 60 years or older were enrolled. A total of 27,564 patients were prospectively followed up from January 1, 2017 to December 31, 2020. The 3-year cumRHR was calculated. The primary outcome was RRFD, defined as an annualized decline in eGFR of 5 mL/min per 1.73 m2 or greater. Logistic and restricted spline regression models and subgroup analysis were used to investigate the association of cumRHR with RRFD after adjusting for all confounders.

RESULTS

During a median follow-up of 3.2 years, a total of 4,347 (15.77%) subjects developed RRFD. In fully-adjusted models, compared with the lowest quartile of cumRHR, the odds ratio (OR) for the highest was 1.44 (1.28–1.61), P < 0.001. Furthermore, each 1-standard deviation (27.97 beats/min per year) increment in cumRHR was associated with a 17% (P < 0.001) increased risk of RRFD, with a linear positive correlation (P for non-linear = 0.803). Participants with a 3-year cumRHR ≥ 207 (beats/min) * year (equivalent to ≥ 69 beats/min per year in 3 years) were found to be at a higher risk of RRFD.

CONCLUSIONS

The cumRHR is significantly associated with a higher risk of RRFD among older adults. These results might provide an effective goal for managing and delaying the decline of renal function in the older adults.

Electronic Supplementary Material

Download File(s)
JGC-202303-031R1Supp.pdf (4.2 MB)

References

[1]

Jha V, Garcia-Garcia G, Iseki K, et al. Chronic kidney disease: global dimension and perspectives. Lancet 2013; 382: 260−272.

[2]

Collaboration GBDCKD. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2020; 395: 709−733.

[3]

Wang L, Xu X, Zhang M, et al. Prevalence of Chronic Kidney Disease in China: Results From the Sixth China Chronic Disease and Risk Factor Surveillance. JAMA Intern Med 2023; 183: 298−310.

[4]

Valentini M, Parati G. Variables influencing heart rate. Prog Cardiovasc Dis 2009; 52: 11−19.

[5]

Bielecka-Dabrowa A, von Haehling S, Rysz J, Banach M. Novel drugs for heart rate control in heart failure. Heart Fail Rev 2018; 23: 517−525.

[6]

Kercheva M, Ryabov V, Gombozhapova A, et al. Macrophages of the "heart-kidney" axis: their dynamics and correlations with clinical data and outcomes in patients with myocardial infarction. J Pers Med 2022; 12: 127.

[7]

Glorieux G, Nigam SK, Vanholder R, Verbeke F. Role of the microbiome in gut-heart-kidney cross talk. Circ Res 2023; 132: 1064−1083.

[8]

Grassi G, Quarti-Trevano F, Seravalle G, et al. Early sympathetic activation in the initial clinical stages of chronic renal failure. Hypertension 2011; 57: 846−851.

[9]

Böhm M, Reil JC, Danchin N, et al. Association of heart rate with microalbuminuria in cardiovascular risk patients: data from I-SEARCH. J Hypertens 2008; 26: 18−25.

[10]

Peng X, Li Y, Wang X, et al. Relationship between resting heart rate and microalbuminuria in adults with hypertension: national health and nutrition examination survey 2009-2018. Front Cardiovasc Med 2022; 9: 739113.

[11]

Schmieder R, Bramlage P, Haller H, et al. The effect of resting heart rate on the new onset of microalbuminuria in patients with type 2 diabetes: a sub-analysis of the ROADMAP Study. Medicine 2016; 95: e3122.

[12]

Chang YK, Fan HC, Lim PS, et al. The relationship between resting heart rate and new-onset microalbuminuria in people with type 2 diabetes: An 8-year follow-up study. Diabet Med 2021; 38: e14436.

[13]

Miot A, Ragot S, Hammi W, et al. Prognostic value of resting heart rate on cardiovascular and renal outcomes in type 2 diabetic patients: a competing risk analysis in a prospective cohort. Diabetes Care 2012; 35: 2069−2075.

[14]

Voors AA, van Veldhuisen DJ, Robertson M, et al. The effect of heart rate reduction with ivabradine on renal function in patients with chronic heart failure: an analysis from SHIFT. Eur J Heart Fail 2014; 16: 426−434.

[15]

Bohm M, Schumacher H, Schmieder RE, et al. Resting heart rate is associated with renal disease outcomes in patients with vascular disease: results of the ONTARGET and TRANSCEND studies. J Intern Med 2015; 278: 38−49.

[16]

Inoue T, Iseki K, Iseki C, et al. Heart rate as a risk factor for developing chronic kidney disease: longitudinal analysis of a screened cohort. Clin Exp Nephrol 2009; 13: 487−493.

[17]

Mao W, Jin X, Wang H, et al. The Association between Resting Heart Rate and Urinary Albumin/Creatinine Ratio in Middle-Aged and Elderly Chinese Population: A Cross-Sectional Study. J Diabetes Res 2019; 2019: 9718370.

[18]

Pfister R, Erdmann E, Schneider CA. Association and prognostic impact of heart rate and micro- albuminuria in patients with type 2 diabetes and cardiovascular disease: results from the PROactive trial. J Atheroscler Thromb 2011; 18: 65−71.

[19]

Bartakova V, Klimesova L, Kianickova K, et al. Resting heart rate does not predict cardiovascular and renal outcomes in type 2 diabetic patients. J Diabetes Res 2016; 2016: 6726492.

[20]

de Vocht F, Burstyn I, Sanguanchaiyakrit N. Rethinking cumulative exposure in epidemiology, again. J Expo Sci Environ Epidemiol 2015; 25: 467−473.

[21]

Zhao Q, Li H, Wang A, et al. Cumulative resting heart rate exposure and risk of all-cause mortality: results from the Kailuan cohort study. Sci Rep 2017; 7: 40212.

[22]

Yu J, Dai L, Zhao Q, et al. Association of cumulative exposure to resting heart rate with risk of stroke in general population: The Kailuan Cohort Study. J Stroke Cerebrovasc Dis 2017; 26: 2501−2509.

[23]

Inker LA, Astor BC, Fox CH, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis 2014; 63: 713−735.

[24]

Navaneethan SD, Zoungas S, Caramori ML, et al. Diabetes management in chronic kidney disease: synopsis of the KDIGO 2022 Clinical Practice Guideline Update. Ann Intern Med 2023; 176: 381−387.

[25]

Brotman DJ, Bash LD, Qayyum R, et al. Heart rate variability predicts ESRD and CKD-related hospitalization. J Am Soc Nephrol 2010; 21: 1560−1570.

[26]

Wang Y, Yin L, Hu B, et al. Association of heart rate with cardiovascular events and mortality in hypertensive and normotensive population: a nationwide prospective cohort study. Ann Transl Med 2021; 9: 917.

[27]

Converse RL, Jr. Jacobsen TN, Toto RD, et al. Sympathetic overactivity in patients with chronic renal failure. N Engl J Med 1992; 327: 1912−1918.

[28]

Custodis F, Baumhakel M, Schlimmer N, et al. Heart rate reduction by ivabradine reduces oxidative stress, improves endothelial function, and prevents atherosclerosis in apolipoprotein E-deficient mice. Circulation 2008; 117: 2377−2387.

[29]
Giannoglou GD, Chatzizisis YS, Zamboulis C, et al. Elevated heart rate and atherosclerosis: an overview of the pathogenetic mechanisms. Int J Cardiol. 2008; 126: 302-312.
[30]

Hill GS, Heudes D, Bariéty J. Morphometric study of arterioles and glomeruli in the aging kidney suggests focal loss of autoregulation. Kidney Int 2003; 63: 1027−1036.

[31]

Whelton SP, Narla V, Blaha MJ, et al. Association between resting heart rate and inflammatory biomarkers (high-sensitivity C-reactive protein, interleukin-6, and fibrinogen) (from the Multi-Ethnic Study of Atherosclerosis). Am J Cardiol 2014; 113: 644−649.

Journal of Geriatric Cardiology
Pages 673-683
Cite this article:
JIANG X, SHAO X, LI X, et al. Association of cumulative resting heart rate exposure with rapid renal function decline: a prospective cohort study with 27,564 older adults. Journal of Geriatric Cardiology, 2023, 20(9): 673-683. https://doi.org/10.26599/1671-5411.2023.09.009

629

Views

33

Downloads

0

Crossref

1

Web of Science

1

Scopus

0

CSCD

Altmetrics

Published: 28 September 2023
© 2023 JGC All rights reserved
Return